English
Regional settings| Spread | 0.08 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ €5,000.00 Short position overnight fee ~ €4,000.00 | -0.022091% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ €5,000.00 Short position overnight fee ~ €4,000.00 | -0.000132% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | EUR | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | France | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 10.66 |
| Open | 10.4 |
| 1-Year Change | -55.95% |
| Day's Range | 10.39 - 10.69 |
Nexity SA is a residential and commercial real estate developer based in Paris, France. As a developer of residential real estate, the Company provides solutions in individual houses, apartment buildings, and the full development of neighborhoods complete with homes available for rent or purchase, commercial spaces and public facilities. It has various subsidiaries engaged in different divisions, such as Nexity Entreprises specializes in high-rise buildings, new office buildings and structural renovations. Geprim specializes in warehouses, distribution centers and mixed-use units. Nexity Services provides services during every stage of a project design, purchase, daily management, renovation and sale. The Group is also active internationally and it is present in Belgium, Spain, Italy and Portugal. It operates through Costame, among others.
BRIEF: For the fiscal year ended 31 December 2021, Nexity SA revenues decreased 1% to EUR4.47B. Net income increased from EUR118.1M to EUR324.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Dep of Fin Lease Right-of-Use Assets decrease of 36% to EUR124.8M (expense), Depreciation/Amortization/Impairment decrease of 35% to EUR32.8M (expense).
